相关实验视频
Updated: Jul 12, 2025

06:09
Quantification of Tumor Cell Adhesion in Lymph Node Cryosections
Published on: February 9, 2020
12.1K
天生的淋巴细胞和瘤衍生的乳酸:在一个持久的游戏中,新的竞争者
Mateusz Marciniak1, Marek Wagner1,2
1Cancer Biomarkers Research Group, Łukasiewicz Research Network - PORT Polish Center for Technology Development, Wrocław, Poland.
Frontiers in immunology
|October 23, 2023
概括
瘤细胞是一种瘤细胞.
科学领域:
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
- 代谢途径 代谢途径
背景情况:
- 有氧糖解 (Warburg效应) 是癌症代谢的标志,促进瘤生长和扩散.
- 癌细胞将葡萄糖转向乳酸生产,导致瘤微环境酸化.
- 瘤微环境的酸化抑制了抗瘤免疫反应.
研究的目的:
- 研究瘤衍生乳酸对先天性淋巴细胞 (ILC) 的影响.
- 探索针对癌症中的乳酸-ILC轴的潜在治疗策略.
- 将发现转化为针对皮肤癌的向疗法,考虑到皮肤中的ILC丰富性.
主要方法:
- 分析乳酸对先天性淋巴细胞的影响.
- 探索治疗干预的方法.
- 专注于皮肤癌,因为皮肤上存在高水平的ILC.
主要成果:
- 瘤衍生的乳酸显著影响先天性淋巴细胞功能.
- 针对乳酸代谢的治疗策略可以调节免疫反应.
- 了解这种相互作用为新的皮肤癌治疗提供了潜力.
结论:
- 癌细胞产生的乳酸会影响先天性淋巴细胞,影响瘤微环境.
- 向乳酸为癌症免疫疗法提供了一个有前途的途径,特别是皮肤癌.
- 对乳酸-ILC相互作用的进一步研究可以导致有效的治疗策略.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Tumor Immunotherapy
538
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
538
Lymphoid Cells and Tissues
1.2K
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
1.2K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K

